Cargando…
LRRC8A Is a Promising Prognostic Biomarker and Therapeutic Target for Pancreatic Adenocarcinoma
SIMPLE SUMMARY: Pancreatic adenocarcinoma (PAAD) is a highly malignant tumor with a poor prognosis and lack of effective biomarkers. We demonstrated, using bioinformatics analyses, that the leucine-rich repeat-containing 8A (LRRC8A) can affect the prognosis of patients with PAAD. In addition, experi...
Autores principales: | Xu, Rong, Hu, Yaohua, Xie, Qinghua, Zhang, Caiqin, Zhao, Yong, Zhang, He, Shi, Hailong, Wang, Xiaoming, Shi, Changhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688930/ https://www.ncbi.nlm.nih.gov/pubmed/36428619 http://dx.doi.org/10.3390/cancers14225526 |
Ejemplares similares
-
LRRC8A critically regulates myofibroblast phenotypes and fibrotic remodeling following myocardial infarction
por: Chen, Xiyao, et al.
Publicado: (2022) -
Loss of the Volume-regulated Anion Channel Components LRRC8A and LRRC8D Limits Platinum Drug Efficacy
por: Widmer, Carmen A., et al.
Publicado: (2022) -
MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
por: Brunetti, Oronzo, et al.
Publicado: (2015) -
LRRC8A promotes the initial development of oxaliplatin resistance in colon cancer cells
por: Zhang, Haifeng, et al.
Publicado: (2023) -
Allosteric modulation of LRRC8 channels by targeting their cytoplasmic domains
por: Deneka, Dawid, et al.
Publicado: (2021)